Emerging role of interleukin-22 in autoimmune diseases
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Interleukin-22 (IL-22) is an IL-10 family cytokine member that was recently discovered to be mainly produced by Th17 cells. Previous studies have indicated the importance of IL-22 in host defense against Gram-negative bacterial organisms (in gut and lung). Recently, there is emerging evidence that IL-22 is involved in the development and pathogenesis of several autoimmune diseases, such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), multiple sclerosis (MS), Sjögren’s syndrome (SS) and psoriasis. Therapeutics targeting IL-22 therefore may have promise for treating various autoimmune diseases. In this review, we discuss the recent progression of the involvement of IL-22 in the development and pathogenesis of autoimmune diseases, as well as its clinical implications and therapeutic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330 · cited 2×
“IL-22 was originally thought to be a Th1-associated cytokine, it is now recognized that IL-22 is highly expressed by IL-17producing cells, called Th17 cells [2].”
BackgroundThe aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B. (2008) · Nature · doi:10.1038/nature06881 · Cited by 1,634
Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A., & Sallusto, F. (2009) · Nature Immunology · doi:10.1038/ni.1767 · Cited by 1,079 · cited 1×
“Interleukin-22 (IL-22) is a cytokine produced by several different cellular sources including Th17 cells [1, 2], natural killer (NK) 22 cells [3], and Th22 cells [4, 5].”
BackgroundTh22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling
Eyerich, S., Eyerich, K., Pennino, D., Carbone, T., Nasorri, F., Pallotta, S., Cianfarani, F., Odorisio, T., Traidl-Hoffmann, C., Behrendt, H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40202 · Cited by 1,052
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
Pickert, G., Neufert, C., Leppkes, M., Zheng, Y., Wittkopf, N., Warntjen, M., Lehr, H.-A., Hirth, S., Weigmann, B., Wirtz, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082683 · Cited by 1,043 · cited 1×
“The phosphorylation of STAT3 is an essential pathway in mediating the effects of IL-22 on epithelial cells at barrier surfaces, as phosphorylation of STAT3 in intestinal epithelial cells following chemical-induced colitis is IL-22-dependent; additionally, conditional deletion of epithelial-intrinsic STAT3 from intesti…”
BackgroundTrifari, S., Kaplan, C. D., Tran, E. H., Crellin, N. K., & Spits, H. (2009) · Nature Immunology · doi:10.1038/ni.1770 · Cited by 1,021
Interleukin-22: A novel T- and NK-cell derived cytokine that regulates the biology of tissue cells
Wolk, K., & Sabat, R. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.001 · Cited by 303 · cited 3×
“Like other IL-10 family members, IL-22 also has an α-helical secondary structure [26].”
BackgroundDexamethasone suppresses interleukin-22 associated with bacterial infection in vitro and in vivo
Ziesché, E., Scheiermann, P., Bachmann, M., Sadik, C. D., Hofstetter, C., Zwissler, B., Pfeilschifter, J., & Mühl, H. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03969.x · Cited by 40 · cited 3×
“Ziesché et al [8] suggest that those disparate observations may reflect diverse molecular mechanisms directing IL-22 production in the context of innate and adaptive immunity.”
BackgroundInfluential
Cited by
Emerging role of long noncoding RNAs in autoimmune diseases
Wu, G.-C., Pan, H.-F., Leng, R.-X., Wang, D.-G., Li, X.-P., Li, X.-M., & Ye, D.-Q. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.05.004 · Cited by 263
Self-citationThe Pathogenesis of Hashimoto’s Thyroiditis: Further Developments in our Understanding
Ajjan, R. A., & Weetman, A. P. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1548832 · Cited by 259
Interleukin-22 Signaling in the Regulation of Intestinal Health and Disease
Parks, O. B., Pociask, D. A., Hodzic, Z., Kolls, J. K., & Good, M. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00085 · Cited by 175
“Increased IL-22 levels can also recruit pathologic effector cells to the inflamed tissue site, most noticeably in autoimmune diseases in other tissues (Pan et al., 2013).”
BackgroundClinical and immunological parameters of Sjögren's syndrome
Psianou, K., Panagoulias, I., Papanastasiou, A. D., de Lastic, A.-L., Rodi, M., Spantidea, P. I., Degn, S. E., Georgiou, P., & Mouzaki, A. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.05.005 · Cited by 171
Ivanov, S., Renneson, J., Fontaine, J., Barthelemy, A., Paget, C., Fernandez, E. M., Blanc, F., De Trez, C., Van Maele, L., Dumoutier, L., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02943-12 · Cited by 161
“Since in humans, dysregulation of IL-22 or IL-22 receptor production has been reported in certain pathologies, including psoriasis, Crohn’s disease, and allergic diseases (80), it might be interesting to determine the potential correlation, if any, between susceptibility to bacterial superinfections and IL-22 or IL-22…”
BackgroundImmunomodulatory activity of interferon‐beta
Kasper, L. H., & Reder, A. T. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.84 · Cited by 159
Impact of antidepressants on cytokine production of depressed patients in Vitro
Munzer, A., Sack, U., Mergl, R., Schönherr, J., Petersein, C., Bartsch, S., Kirkby, K., Bauer, K., & Himmerich, H. (2013) · Toxins · doi:10.3390/toxins5112227 · Cited by 114
“Studies have indicated the importance of IL-22 in host defense and in the development and pathogenesis of several autoimmune diseases [25].”
BackgroundImpact of mood stabilizers and antiepileptic drugs on cytokine production in-vitro
Himmerich, H., Bartsch, S., Hamer, H., Mergl, R., Schönherr, J., Petersein, C., Munzer, A., Kirkby, K. C., Bauer, K., & Sack, U. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.07.026 · Cited by 100
“Studies have indicated the importance of IL-22 in host defense and in the development and pathogenesis of several autoimmune diseases (Pan et al., 2013).”
Background
Metadata
- Authors
- Pan, H.-F., Li, X.-P., Zheng, S. G., & Ye, D.-Q.
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2013-02
- Volume
- 24
- Issue
- 1
- Pages
- 51-57
- ISSN
- 1359-6101 (ISSN-L)
- OpenAlex
- W2020003175
- Cited by
- 117
- References
- 8
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.